Author Correction: Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19.

Saved in:
Bibliographic Details
Title: Author Correction: Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19.
Authors: Lu Y; Guangzhou National Laboratory, Guangzhou, 510005, China.; School of Basic Medical Sciences, Guangzhou Laboratory, Guangzhou Medical University, Guangzhou, 511436, China., Yang Q; Guangzhou National Laboratory, Guangzhou, 510005, China.; State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, 511436, China., Ran T; Guangzhou National Laboratory, Guangzhou, 510005, China., Zhang G; Guangzhou National Laboratory, Guangzhou, 510005, China., Li W; Guangzhou National Laboratory, Guangzhou, 510005, China.; College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, China., Zhou P; Guangzhou National Laboratory, Guangzhou, 510005, China., Tang J; Guangzhou National Laboratory, Guangzhou, 510005, China., Dai M; Guangzhou National Laboratory, Guangzhou, 510005, China., Zhong J; Guangzhou National Laboratory, Guangzhou, 510005, China., Chen H; Guangzhou National Laboratory, Guangzhou, 510005, China., He P; Guangzhou National Laboratory, Guangzhou, 510005, China., Zhou A; School of Basic Medical Sciences, Guangzhou Laboratory, Guangzhou Medical University, Guangzhou, 511436, China., Xue B; Guangzhou National Laboratory, Guangzhou, 510005, China., Chen J; Guangzhou National Laboratory, Guangzhou, 510005, China.; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China., Zhang J; Guangzhou National Laboratory, Guangzhou, 510005, China.; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China., Yang S; Guangzhou National Laboratory, Guangzhou, 510005, China., Wu K; Guangzhou National Laboratory, Guangzhou, 510005, China.; State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin, 300071, China., Wu X; Guangzhou National Laboratory, Guangzhou, 510005, China., Tang M; Guangzhou National Laboratory, Guangzhou, 510005, China., Zhang WK; Guangzhou National Laboratory, Guangzhou, 510005, China., Guo D; Guangzhou National Laboratory, Guangzhou, 510005, China.; State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, 511436, China., Chen X; Guangzhou National Laboratory, Guangzhou, 510005, China. chen_xinwen@gzlab.ac.cn.; State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, 511436, China. chen_xinwen@gzlab.ac.cn., Chen H; Guangzhou National Laboratory, Guangzhou, 510005, China. chen_hongming@gzlab.ac.cn.; School of Basic Medical Sciences, Guangzhou Laboratory, Guangzhou Medical University, Guangzhou, 511436, China. chen_hongming@gzlab.ac.cn., Shang J; Guangzhou National Laboratory, Guangzhou, 510005, China. shang_jinsai@gzlab.ac.cn.; School of Basic Medical Sciences, Guangzhou Laboratory, Guangzhou Medical University, Guangzhou, 511436, China. shang_jinsai@gzlab.ac.cn.
Source: Nature communications [Nat Commun] 2025 Jan 21; Vol. 16 (1), pp. 891. Date of Electronic Publication: 2025 Jan 21.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2041-1723
DOI:10.1038/s41467-025-56341-8